GLP-1 stimulates insulin secretion and augments the insulin-releasing effects of glucose on the pancreatic beta cell
These may include: Monthly subscription services bundling medication, consultations, and monitoring for a fixed monthly fee (typically 200300) Instalment payment plans allowing the cost to be spread over several months Package deals offering discounted rates for 3-, 6-, or 12-month treatment courses Some private medical insurance policies may cover GLP-1 medications for diabetes management if prescribed for a recognised medical condition, though this is relatively uncommon as most UK policies exclude outpatient prescription medicines
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis KEY MARKET PLAYERS Novo Nordisk A/S (Denmark) Eli Lilly and Company (US) Sanofi (France) Hansoh Pharmaceutical Group Co., Ltd
, Zhu, J
Where the problem often begins: loss of muscle in mid-life Although insulin resistance can (and does) happen at any age, as a consequence of an extremely high sugar environment, for many of us, it only creeps in once skeletal muscle mass starts to shrink in our 30s